Observational studyRheumatology (Oxford, England)2021

Defining the optimal disease duration of early diffuse systemic sclerosis for clinical trial design.

Robyn T Domsic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.